BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1663358)

  • 1. [Epidemiologic study of anti-HCV antibodies in Tunisian blood donors].
    Slama H; Mojaat N; Dahri R; Boukef K
    Rev Fr Transfus Hemobiol; 1991 Dec; 34(6):459-64. PubMed ID: 1663358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
    Abdelaal M; Rowbottom D; Zawawi T; Scott T; Gilpin C
    Transfusion; 1994 Feb; 34(2):135-7. PubMed ID: 8310483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
    Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
    Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevalence of anti-HCV positivity among blood donors in Asturias. A clinical-epidemiologic study].
    Suárez A; Rodríguez M; Riestra S; Navascués CA; San Román FS; Otero L; Martínez A; Rodrigo L
    Med Clin (Barc); 1994 Nov; 103(16):606-10. PubMed ID: 7996916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
    Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of HBsAg, anti-HBc and anti-HCV in blood donor candidates at the Campinas hemocenter].
    Gonçales Júnior FL; Boccato RS; Pedro Rde J; Papaiordanou PM; de Souza CA; Gonçales NS; Pellegrino Júnior J
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):45-51. PubMed ID: 7506445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease in anti-hepatitis C virus-positive Norwegian blood donors.
    Nordøy I; Schrumpf E; Elgjo K; Flesland O; Andersen Glende J; Orjasaeter H; Siebke JC
    Scand J Gastroenterol; 1994 Jan; 29(1):77-81. PubMed ID: 8128181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of non-A non-B hepatitis and anti-HCV antibodies in a Portuguese dialysis population.
    Carrera F; Silva JG; Pires C; Oliveira C
    Nephrol Dial Transplant; 1992; 7(9):913-6. PubMed ID: 1383874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viral hepatitis and blood transfusion].
    Larsen J; Hetland G; Skaug K; Maeland A
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of anti-HCV among voluntary blood donors in Taiwan.
    Tsai SJ; Chen CJ; Hsieh YS; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):61-70. PubMed ID: 1657546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
    Abb J
    Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-A, non-B hepatitis and the anti-HCV assay.
    Barbara JA; Contreras M
    Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anti-HCV in subjects of various age groups.
    Albano A; Pianetti A; Biffi MR; Bruscolini F; Baffone W; Albano V; Salvaggio A
    Eur J Epidemiol; 1992 Mar; 8(2):309-11. PubMed ID: 1379536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibody to hepatitis C virus in a blood donor population.
    Richards C; Holland P; Kuramoto K; Douville C; Randell R
    Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.